Market Cap: $42.14M
Filed a patent for "compositions and methods comprising anti-nrp2 antibodies" on Fri, June 17, 2022
Filed a patent for "compositions and methods comprising anti-nrp2 antibodies" on Thu, October 5, 2023
Filed a patent for "compositions and methods comprising anti-nrp2 antibodies" on Thu, March 21, 2024
